Enanta Pharmaceuticals Inc (ENTA)

[Rocky3]

From the Japanese drug email list -


AbbVie’s hepatitis C drug Maviret (glecaprevir + pibrentasvir) was by far the best-selling medicine in Japan in April-September, but its sales appear to have already peaked out thanks to its own success. The shrinking market signals that the industry is on track to the elimination of the disease by 2030, as advocated by the WHO ...